Chemistry:Perflenapent
From HandWiki
| |
| |
| Names | |
|---|---|
| Preferred IUPAC name
Dodecafluoropentane[1] | |
| Other names
Perfluoropentane
| |
| Identifiers | |
3D model (JSmol)
|
|
| 1712388 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| EC Number |
|
| KEGG | |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C5F12 | |
| Molar mass | 288.036 g·mol−1 |
| Density | 1.63 g/mL (liquid, 25 °C) [2] 1.59 g/mL (liquid, 35 °C) 12.25 kg/m³ (gas, 1 atm, 10 times air density) |
| Melting point | −115 °C (−175 °F; 158 K) |
| Boiling point | 28 °C (82 °F; 301 K) Heat of vaporization = 21 cal/g |
| Vapor pressure | 83.99 kPa (25 °C) |
| Viscosity | 0.652 mPa*s (25 °C) |
| Thermochemistry | |
Heat capacity (C)
|
0.26 cal/(g • K) |
| Pharmacology | |
| 1=ATC code }} | V08DA03 (WHO) |
| Hazards | |
| GHS pictograms | 
|
| GHS Signal word | Warning |
| H315, H319, H335 | |
| P261, P264, P271, P280, P302+352, P304+340, P305+351+338, P312, P321, P332+313, P337+313, P362, P403+233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Tracking categories (test):
Perflenapent (INN/USAN; also known as perfluoropentane (PFP) and dodecafluoropentane) is a fluorocarbon, the fluorinated analogue of pentane. It is a liquid that boils at slightly over room temperature.
It has several biomedical applications including: propellant for pressurized metered dose inhalers;[3] gas core in microbubble ultrasound contrast agents;[4] and occlusion therapy via the conversion of nanometer liquid droplets into micrometer sized gas microbubbles (acoustic droplet vaporization).[5]
References
- ↑ Nomenclature of Organic Chemistry : IUPAC Recommendations and Preferred Names 2013 (Blue Book). Cambridge: The Royal Society of Chemistry. 2014. p. 33. doi:10.1039/9781849733069-FP001. ISBN 978-0-85404-182-4. "The prefix ‘per-’ is no longer recommended."
- ↑ "Perfluoropentane". http://www.fluoromed.com/products/perfluoropentane/.
- ↑ Rogueda, P. G. A. HPFP, a Model Propellant for pMDIs. Drug Dev. Ind. Phar. 2003, 29, 39
- ↑ Liu, Y., Miyoshi, H., and Nakamura, M. Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene delivery. J. Controlled Release 2006, 114, 89− 99
- ↑ D. Bardin, T. D. Martz, P. S. Sheeran, R. Shih, P. A. Dayton, and A. P. Lee, “High-speed, clinical-scale microfluidic generation of stable phase-change droplets for gas embolotherapy,” Lab on a Chip, vol. 11, no. 23, p. 3990, 2011.
 |
